Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€60.00
24.10.23
-
24.10.24
-0.13%
28.10.23

Could be worthwhile Investment >10% per year
buy
Seres Therapeutics Inc

Start price
Target price
Perf. (%)
€1.50
24.10.23
-
24.10.24
-12.00%
28.10.23

Could be worthwhile Investment >10% per year
buy
Tupperware Brands Corp.

Start price
Target price
Perf. (%)
€1.69
20.10.23
-
20.10.24
-12.86%
28.10.23

Risky Investment
buy
Assembly Biosciences Inc.

Start price
Target price
Perf. (%)
€1.02
18.10.23
-
18.10.24
-25.59%
28.10.23

Could be worthwhile Investment >10% per year
buy
flatexDEGIRO AG

Start price
Target price
Perf. (%)
€9.74
18.10.23
€10.00
18.10.24
9.75%
15.11.23

EBIT growth > 30% per year expected
Known brand
Future proof or reliable business model
Higher EBIT margin than peer group
buy
Deutsche Rohstoff AG

Start price
Target price
Perf. (%)
€33.60
18.10.23
€34.00
18.10.24
3.27%
08.03.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Rising EBIT margin expected
Fair valuation
Tempest Therapeutics Inc.

Start price
Target price
Perf. (%)
€7.50
17.10.23
-
17.10.24
-48.27%
29.10.23

Could be worthwhile Investment >10% per year
buy
Revolution Medicines Inc.

Start price
Target price
Perf. (%)
€32.20
16.10.23
€43.00
30.09.25
28.57%
13.07.24

Could be very worthwhile Investment >20% year
Tempest Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.96
16.10.23
-
16.10.24
-21.77%
28.10.23

Capable Management
Good culture
No Innovation
Risky Investment
buy
Omeros Corp.

Start price
Target price
Perf. (%)
€1.12
16.10.23
-
16.10.24
26.57%
16.10.23

Could be worthwhile Investment >10% per year
Good culture
Innovative
Few uniques
buy
Aldeyra Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.39
16.10.23
-
16.10.24
61.90%
16.10.23

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
Bovie Medical Corp

Start price
Target price
Perf. (%)
€2.34
16.10.23
-
16.10.24
-15.38%
11.12.23

Risky Investment
Cellectis Nom.

Start price
Target price
Perf. (%)
€1.26
16.10.23
-
16.10.24
95.87%
19.01.24

Risky Investment
buy
Tempest Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.92
16.10.23
-
16.10.24
-1.02%
29.10.23

Probably not worthwhile Investment
buy
Aixtron SE

Start price
Target price
Perf. (%)
€29.59
16.10.23
€35.00
16.10.24
-4.33%
26.10.23

Could be worthwhile Investment >10% per year
Very capable Management
Very good company culture
Strong uniques
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.67
16.10.23
-
16.10.24
-3.95%
28.10.23

Could be very worthwhile Investment >20% year
Tempest Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.05
11.10.23
-
11.10.24
423.81%
12.10.23

Could be very worthwhile Investment >20% year
buy
Tupperware Brands Corp.

Start price
Target price
Perf. (%)
€1.31
10.10.23
-
10.10.24
57.25%
15.10.23

Risky Investment
buy
888 Holdings plc

Start price
Target price
Perf. (%)
€1.08
10.10.23
€1.50
10.10.24
-10.90%
10.12.23

Could be worthwhile Investment >10% per year
buy
Euronav S.A.

Start price
Target price
Perf. (%)
€16.88
10.10.23
-
10.10.24
-3.44%
31.01.24

buy
Northern Data AG

Start price
Target price
Perf. (%)
€25.35
10.10.23
-
10.10.24
7.69%
31.01.24

buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.63
09.10.23
-
09.10.24
2.61%
15.10.23

Could be worthwhile Investment >10% per year
buy
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.34
09.10.23
-
09.10.24
9.91%
15.10.23

Could be worthwhile Investment >10% per year
buy
Vitesco Technologies Group AG

Start price
Target price
Perf. (%)
€89.55
07.10.23
-
07.10.24
-22.05%
11.03.24

buy
Paragon AG

Start price
Target price
Perf. (%)
€4.97
06.10.23
-
06.10.24
-23.34%
28.12.23